April 19, 2018 / 12:25 PM / 3 months ago

Takeda in talks with Shire after 46.50 stg/shr bid rejected

LONDON, April 19 (Reuters) - Japan's Takeda Pharmaceutical said on Thursday it was in negotiations with Shire after making a bid worth 46.50 pounds per share that was rejected by the London-listed rare diseases drugmaker.

Reuters first reported that Takeda had made the cash-and-stock takeover offer, valuing Shire at around $61 billion. (Reporting by Ben Hirschler; Editing by Susan Fenton)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below